Moreover, a recent study has shown that activation of the axial mechanism of liver-X nuclear receptor (LXR) and ApoE by pharmacological agents can elicit an immune response against a variety of cancers, such as glioblastoma, ovarian, renal, colon cancers, and lung cancer [29]. Here, APOE is linked to lung carcinoma.